The sample density problem of AF mapping:
The ever changing activation during AF confounds current technologies which depend upon activation mapping. With our high resolution array, CoreMap can map the electrical properties of atrial tissue that determine where AF drivers localize.
The critical advantage of tissue property mapping over activation mapping is that tissue properties do not change and thus data can be acquired sequentially, so there is effectively no limit to the number of data points that can be sampled during AF.
